NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines

Published:2018-12 Issue:7 Volume:175 Page:1744-1755.e15
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

van Montfoort Nadine,Borst Linda,Korrer Michael J.,Sluijter Marjolein,Marijt Koen A.,Santegoets Saskia J.,van Ham Vanessa J.,Ehsan Ilina,Charoentong Pornpimol,André Pascale,Wagtmann Nicolai,Welters Marij J.P.,Kim Young J.,Piersma Sytse J.,van der Burg Sjoerd H.,van Hall Thorbald

Funder

Dutch Cancer Society

Innate Pharma

NIH

Amy and Barry Baker Lab

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference57 articles.

1. IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer;Abiko;Br. J. Cancer,2015

2. Non-classical HLA-class I expression in serous ovarian carcinoma: correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis;Andersson;OncoImmunology,2015

3. Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells;André;Cell,2018

4. Human NK cell education by inhibitory receptors for MHC class I;Anfossi;Immunity,2006

5. Human papillomavirus and survival of patients with oropharyngeal cancer;Ang;N. Engl. J. Med.,2010

Cited by 261 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA-E and NKG2A Mediate Resistance toM. bovisBCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer;2024-09-03

2. GNA14 may be a potential prognostic biomarker in nasopharyngeal carcinoma;2024-09-02

3. Maintaining the Balance: Regulation of NK Cell Activity;Cells;2024-08-31

4. A role of gut microbiota metabolites in HLA-E and NKG2 blockage immunotherapy against tumors: new insights for clinical application;Frontiers in Immunology;2024-08-20

5. The basic biology of NK cells and its application in tumor immunotherapy;Frontiers in Immunology;2024-08-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3